𝔖 Bobbio Scriptorium
✦   LIBER   ✦

COX-2 and colon cancer

✍ Scribed by M. M. Taketo

Book ID
105753699
Publisher
SP Birkhäuser Verlag Basel
Year
1998
Tongue
English
Weight
167 KB
Volume
47
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COX-2 and colon cancer: Potential target
COX-2 and colon cancer: Potential targets for chemoprevention
✍ David B. Fournier; Gary B. Gordon 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Evidence derived from several lines of investigation suggest that prostaglandins, metabolites of arachidonic acid, play an important role in colon cancer development. Elevated prostaglandin levels are found in colon cancers and their precursor lesions, adenomatous polyps. Agents such as aspirin and

Cox-2 inhibition for the treatment of co
Cox-2 inhibition for the treatment of colon cancer
✍ Carlos Becerra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 30 KB

Aguilar and associates state that the dose of rofecoxib used in our clinical study is insufficient based on experiments in OFA rats whereby the best dose to reduce or prevent colorectal cancer is at least 2.5 mg/kg/day. This dose would represent 3-4-fold increase in the dose given to patients in the

COX-2 inhibitors for colorectal cancer
COX-2 inhibitors for colorectal cancer
✍ Elder, Douglas J. E.; Paraskeva, Christos 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB